What is VisionQuest Biomedical?
VisionQuest Biomedical, founded in 2007 by Dr. Peter Soliz, specializes in developing and delivering advanced artificial intelligence-based imaging technologies designed to enhance healthcare accessibility. The company's core focus is on AI techniques for evaluating digital medical photographs, particularly retinal images, to detect conditions like diabetic retinopathy, a leading cause of blindness. By establishing a network of clinics for study, VisionQuest aims to provide efficient and cost-effective diagnostic tools for both patients and healthcare providers, leveraging AI to improve early detection and management of critical health issues.
How much funding has VisionQuest Biomedical raised?
VisionQuest Biomedical has raised a total of $1.4M across 3 funding rounds:
Debt
$150K
Debt
$227K
Grant
$1M
Debt (2020): $150K with participation from PPP
Debt (2021): $227K led by PPP
Grant (2022): $1M supported by U.S. Department of Health and Human Services
Key Investors in VisionQuest Biomedical
U.S. Department of Health and Human Services
The U.S. Department of Health and Human Services is a government agency dedicated to safeguarding the health of all Americans and providing essential human services. Its involvement suggests a strong alignment with public health initiatives and the advancement of medical technologies.
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for VisionQuest Biomedical?
With the recent influx of $1M through a major strategic investment, VisionQuest Biomedical is poised for significant expansion. This capital infusion is expected to accelerate the development and deployment of its AI-powered imaging solutions, potentially broadening its reach into new markets and enhancing its diagnostic capabilities. The company's focus on addressing critical health concerns like diabetic retinopathy positions it for continued growth and impact within the health-tech industry, likely involving further strategic partnerships and technological advancements.
See full VisionQuest Biomedical company page
